Shnaghai Shengkang Medical Center

Guoxiang Fu0 sites1,000 target enrollmentFebruary 1, 2018

ConditionsVascular Diseases

Overview

Phase: N/A
Intervention: Not specified
Conditions: Vascular Diseases
Sponsor: Guoxiang Fu
Enrollment: 1000
Primary Endpoint: Cardio-ankle vascular index
Last Updated: 8 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The process of population aging that is occurring in developed societies represents a major challenge for the health system. The aim of this study is to analyze factors that have an influence on early vascular aging (EVA), estimated by carotid-femoral pulse wave velocity (cf-PWV) and Cardio Ankle Vascular Index (CAVI), and to determine differences by gender in a Chinese population.

Registry

clinicaltrials.gov

Start Date

February 1, 2018

End Date

May 1, 2021

Last Updated

8 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Guoxiang Fu

Responsible Party

Sponsor Investigator

Principal Investigator

Guoxiang Fu

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Eligibility Criteria

Inclusion Criteria

•• Patients aged 35 to 85 years who agree to participate in the study and do not meet any of the exclusion criteria.

Exclusion Criteria

•• Subjects who are in terminal condition, who cannot travel to the health centers to undergo the corresponding examinations, and those who do not wish to sign the informed consent.
•Subjects with a history of CVD (ischemic heart disease or stroke, peripheral arterial disease or heart failure), diagnosed renal failure in terminal stages (glomerular filtration rate below 30%), chronic inflammatory disease, or acute inflammatory process in the past three months.
•Patients treated with estrogens, testosterone, or growth hormone.